09996.HK
Peijia Medical Limited
HKSE · Healthcare · Medical - Devices · CN
HKD 3.77
−3.83%Year over year
Reported trailing growth
- Revenue
- +17.4%
- EBITDA
- +83.0%
- EBIT
- +45.5%
- EPS
- +37.9%
- Free cash flow
- +76.2%
- Operating cash flow
- -52.2%
Forward estimates
Based on analyst estimates
- Revenue
- +23.3%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +41.6%
- EBITDA
- +24.8%
- EBIT
- +17.0%
- Net income
- +10.3%
- EPS
- +8.8%
- Free cash flow
- -14.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026